SIGA 6.98 SIGA Technologies, Inc.
| Range: | 4.26-12.83 | Vol Avg: | 1424567 | Last Div: | 0.6 | Changes: | 0.27 |
| Beta: | 0.9 | Cap: | 0.49B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Wed Sep 10 1997 | Empoloyees: | 45 | ||
| CUSIP: | 826917106 | CIK: | 0001010086 | ISIN: | US8269171067 | Country: | US |
| CEO: | Dr. Diem Nguyen M.B.A., Ph.D. | Website: | https://www.siga.com | ||||
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Stock Details
Negative -0.30
Siga Technologies to supply mpox therapy in Morocco
Drugmaker Siga Technologies said on Tuesday it would supply its therapy for mpox in Morocc...
reuters.com·Tue Oct 08 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow